Last Updated: November 16, 2026

Details for Patent: 10,774,072

« Back to Dashboard


Which drugs does patent 10,774,072 protect, and when does it expire?

Patent 10,774,072 protects OMLONTI and is included in one NDA.

This patent has eight patent family members in seven countries.

Summary for Patent: 10,774,072
Title:Crystal of N-substituted sulfonamide compound
Abstract:The present invention relates to a method for producing N-substituted sulfonamide compounds including a step of reacting a sulfonamide compound of general formula (1) with a halogenated organic compound of general formula (2) in the presence of cesium carbonate or potassium carbonate in an organic solvent to produce an N-substituted sulfonamide compound of general formula (3).
Inventor(s):Yasuhito Yamamoto, Masayoshi Oue, Yukinori Wada
Assignee: Ube Corp
Application Number:US16/556,978
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 10,774,072

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ocuvex Therap OMLONTI omidenepag isopropyl SOLUTION;OPHTHALMIC 215092-001 Sep 22, 2022 RX Yes Yes 10,774,072 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,774,072

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2951784 ⤷  Start Trial
China 106458904 ⤷  Start Trial
European Patent Office 3156396 ⤷  Start Trial
Spain 2891083 ⤷  Start Trial
Japan 6572891 ⤷  Start Trial
Japan WO2015190507 ⤷  Start Trial
South Korea 20170013994 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.